Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

PCVX holding history

Vaxcyte, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCVX overviewAll 13F holders of PCVXFull Q2 2026 holdings

Shares (Q2 2026)
776,511
Value
$45.1M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PCVX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026776,511$45.1M<0.1%−560,879−41.9%ReducedHolders
Q1 20261,337,390$77.7M<0.1%+243,797+22.3%AddedHolders
Q4 20251,093,593$50.5M<0.1%+246,020+29.0%AddedHolders
Q3 2025847,573$30.5M<0.1%−533,280−38.6%ReducedHolders
Q2 20251,380,853$44.9M<0.1%+300,457+27.8%AddedHolders
Q1 20251,080,396$40.8M<0.1%+343,835+46.7%AddedHolders
Q4 2024736,561$60.3M<0.1%+624,988+560.2%AddedHolders
Q3 2024111,573$12.7M<0.1%+15,897+16.6%AddedHolders
Q2 202495,676$7.22M<0.1%−80,402−45.7%ReducedHolders
Q1 2024176,078$12.0M<0.1%+10,044+6.0%AddedHolders
Q4 2023166,034$10.4M<0.1%+91,729+123.4%AddedHolders
Q3 202374,305$3.79M<0.1%+28,483+62.2%AddedHolders
Q2 202345,822$2.29M<0.1%+45,478+13,220.3%AddedHolders
Q1 2023344$12.9K<0.1%−122,376−99.7%ReducedHolders
Q4 2022122,720$5.88M<0.1%+122,645+163,526.7%AddedHolders
Q3 202275$2.00K<0.1%−23,498−99.7%ReducedHolders
Q2 202223,573$513.0K<0.1%−36,814−61.0%ReducedHolders
Q1 202260,387$1.46M<0.1%+15,152+33.5%AddedHolders
Q4 202145,235$1.08M<0.1%−76,552−62.9%ReducedHolders
Q3 2021121,787$3.09M<0.1%+13,884+12.9%AddedHolders
Q2 2021107,903$2.43M<0.1%−7,547−6.5%ReducedHolders
Q1 2021115,450$2.28M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.